Excited to welcome Mike to the @insitro team! Mike has an incredible track record of innovation in clinical trial design, to deliver on the goal of accelerating impact to patients. His contributions will be transformative as we enter the next phase of our journey.
We’re thrilled to welcome Dr. S. Michael Rothenberg as insitro’s CMO. With 2 decades of clinical care & drug development experience, his innovations in data-driven trial design will be critical as we advance our pipeline toward the clinic. businesswire.com/news/home/2…
Jan 8, 2024 · 4:19 PM UTC
